Literature DB >> 8461975

Immunological associations of acquired neuromyotonia (Isaacs' syndrome). Report of five cases and literature review.

J Newsom-Davis1, K R Mills.   

Abstract

Neuromyotonia is a syndrome of spontaneously occurring muscle activity of peripheral nerve origin, which can be triggered by voluntary or induced muscle contraction. It is one among several causes of visible myokymia. Although neuromyotonia may sometimes accompany hereditary neuropathies, most cases are acquired. The abnormal activity is characterized electromyographically by doublet, triplet or multiplet single unit discharges that have a high intraburst frequency, the frequency of the bursts themselves being irregular. Fibrillation potentials and fasciculations are often also present. We report five patients meeting these criteria. Clinical evidence suggesting a possible autoimmune aetiology included the presence of oligoclonal bands in the spinal fluid of the three patients examined and improvement following plasma exchange in two of three patients treated. Other supporting evidence from an English language literature review of approximately 40 patients reported in the last 20 years includes an associated thymoma in five cases, myasthenia gravis (two cases), raised anti-acetylcholine receptor antibody titres (two cases) and induction by penicillamine (one case). Finally, two further patients have recently been reported to benefit from plasma exchange. These clinical data, taken together with the physiological changes observed in mice injected with patients' immunoglobulin G (reported separately), suggest that antibody-mediated autoimmune mechanisms, possibly directed to peripheral nerve K+ channels, may be important in the aetiology of acquired neuromyotonia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8461975     DOI: 10.1093/brain/116.2.453

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  42 in total

1.  Progress in the management of paraneoplastic neurological disorders.

Authors:  Hamid Sadeghian; Steven Vernino
Journal:  Ther Adv Neurol Disord       Date:  2010-01       Impact factor: 6.570

2.  A 45-year history of acquired autoimmune neuromyotonia.

Authors:  Aisling Ryan; Gerard Mullins; Jacqui Scott; Sean Connolly; Orla Hardiman; Emrullah Yilmaz; Angela Vincent; Tim Lynch
Journal:  J Neurol       Date:  2006-09-22       Impact factor: 4.849

3.  Course and outcome of a voltage-gated potassium channel antibody negative Morvan's syndrome.

Authors:  Carlo Rinaldi; Cinzia Valeria Russo; Alessandro Filla; Giuseppe De Michele; Enrico Marano
Journal:  Neurol Sci       Date:  2009-03-04       Impact factor: 3.307

4.  A 48-year-old man with syncope and diffuse muscle twitches.

Authors:  Jenelle A Jindal; Michael A Seidman; Joshua P Klein
Journal:  Neurohospitalist       Date:  2012-07

5.  Morvan's fibrillary chorea: a paraneoplastic manifestation of thymoma.

Authors:  E K Lee; R A Maselli; W G Ellis; M A Agius
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-12       Impact factor: 10.154

6.  Cold-induced neuromyotonia.

Authors:  M de Carvalho; L Albuquerque
Journal:  J Neurol       Date:  1996-08       Impact factor: 4.849

7.  Morvan's fibrillary chorea: remission after plasmapheresis.

Authors:  A Madrid; A Gil-Peralta; E Gil-Néciga; J R González; S Jarrín
Journal:  J Neurol       Date:  1996-04       Impact factor: 4.849

8.  Anesthetic experience using total intravenous anesthesia in a patient with Isaacs' syndrome -A case report-.

Authors:  Young Mi Kim; Sang Hoon Lee; Cheol Sig Han; Eun Mi Choi; Young Ryong Choi; Mi Hwa Chung
Journal:  Korean J Anesthesiol       Date:  2013-02-15

Review 9.  [Isaacs' syndrome. Diagnosis and differential diagnosis of neuromyotonia].

Authors:  D Fischer; R Schröder
Journal:  Nervenarzt       Date:  2004-06       Impact factor: 1.214

10.  Acquired neuromyotonia following upper respiratory tract infection: a case report.

Authors:  Ibrahim Imam; Simon Edwards; C Oliver Hanemann
Journal:  Cases J       Date:  2009-09-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.